HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Bironzo Selected Research

Thymidylate Synthase

8/2022Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition.
8/2022Immunohistochemistry with 3 different clones in anaplastic lymphoma kinase fluorescence in situ hybridization positive non-small-cell lung cancer with thymidylate synthase expression analysis: a multicentre, retrospective, Italian study.
8/2022Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition.
1/2021Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Bironzo Research Topics

Disease

35Neoplasms (Cancer)
04/2024 - 04/2012
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 04/2012
11Lung Neoplasms (Lung Cancer)
01/2024 - 05/2018
7Mesothelioma
04/2024 - 11/2018
7Malignant Mesothelioma
03/2023 - 11/2018
4Adenocarcinoma of Lung
05/2023 - 01/2021
3Sarcoma (Soft Tissue Sarcoma)
01/2024 - 12/2014
3Brain Neoplasms (Brain Tumor)
12/2023 - 09/2023
3Neoplasm Metastasis (Metastasis)
12/2023 - 11/2020
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2023 - 02/2016
3Disease Progression
05/2021 - 02/2016
3Prostatic Neoplasms (Prostate Cancer)
01/2018 - 12/2013
2Adenocarcinoma
05/2023 - 04/2023
2Infections
01/2023 - 01/2020
2COVID-19
01/2022 - 01/2021
2Pleurisy (Pleuritis)
01/2021 - 01/2019
2Colorectal Neoplasms (Colorectal Cancer)
05/2018 - 01/2017
1Thrombosis (Thrombus)
01/2024
1Hepatitis B
01/2023
1Lung Diseases (Lung Disease)
08/2021
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Solitary Fibrous Tumors
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Synovial Sarcoma (Synovioma)
01/2021
1Fibroma (Fibromatosis)
01/2021
1Fasciitis (Fascitis)
01/2021
1Hyperplasia
01/2021
1Aggressive Fibromatosis (Desmoid)
01/2021
1Hemangiosarcoma (Angiosarcoma)
01/2021
1Leiomyosarcoma
01/2021
1Circulating Neoplastic Cells
12/2020
1Pulmonary Arterial Hypertension
01/2019

Drug/Important Bio-Agent (IBA)

18Immune Checkpoint InhibitorsIBA
01/2024 - 09/2017
8Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2017
5Tyrosine Kinase InhibitorsIBA
12/2023 - 12/2014
4ErbB Receptors (EGF Receptor)IBA
12/2023 - 07/2012
4pembrolizumabIBA
10/2023 - 09/2019
4Cisplatin (Platino)FDA LinkGeneric
01/2023 - 04/2012
4Thymidylate SynthaseIBA
08/2022 - 01/2021
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2024 - 01/2021
3PlatinumIBA
12/2023 - 04/2012
3Anaplastic Lymphoma KinaseIBA
11/2023 - 12/2020
3B7-H1 AntigenIBA
08/2023 - 11/2020
3Pemetrexed (MTA)FDA Link
08/2022 - 11/2018
3DNA (Deoxyribonucleic Acid)IBA
07/2022 - 04/2012
3AsbestosIBA
05/2021 - 11/2018
3abirateroneIBA
01/2018 - 12/2013
2niraparibIBA
12/2023 - 01/2021
2dostarlimabIBA
12/2023 - 01/2021
2Programmed Cell Death 1 ReceptorIBA
08/2023 - 12/2014
2Messenger RNA (mRNA)IBA
01/2023 - 04/2012
2Proteins (Proteins, Gene)FDA Link
08/2022 - 08/2022
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2021 - 01/2021
2Carboplatin (JM8)FDA LinkGeneric
04/2018 - 02/2016
2Hormones (Hormone)IBA
01/2018 - 12/2013
2AndrogensIBA
01/2018 - 12/2013
2enzalutamideIBA
01/2018 - 12/2015
1Antineoplastic Agents (Antineoplastics)IBA
01/2024
1Cytotoxins (Cytolysins)IBA
01/2024
1pralsetinibIBA
12/2023
1N 30IBA
12/2023
1patritumab deruxtecanIBA
12/2023
1Letrozole (Femara)FDA LinkGeneric
10/2023
1Estrogen ReceptorsIBA
10/2023
1Aromatase InhibitorsIBA
10/2023
1Estradiol (Delestrogen)FDA LinkGeneric
10/2023
1Colloids (Colloid)IBA
05/2023
1Circular RNAIBA
05/2023
1RNA (Ribonucleic Acid)IBA
05/2023
1Cell-Free Nucleic AcidsIBA
05/2023
1Proto-Oncogene Proteins c-metIBA
02/2023
1COVID-19 VaccinesIBA
01/2023
1BNT162 VaccineIBA
01/2023
1AntibodiesIBA
01/2023
1Opioid Analgesics (Opioids)IBA
12/2022
1MicroRNAs (MicroRNA)IBA
08/2022
1Codon (Codons)IBA
05/2022
1Thioredoxin-Disulfide ReductaseIBA
05/2022
1defactinibIBA
05/2022
1pevonedistatIBA
02/2022
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022
1PM 01183IBA
05/2021
1InterferonsIBA
01/2021
11-methyl-1-piperidinomethane sulfonateIBA
01/2021
1durvalumabIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Circulating Tumor DNAIBA
12/2020
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1MucinsIBA
01/2019

Therapy/Procedure

16Immunotherapy
04/2024 - 12/2018
16Therapeutics
01/2024 - 07/2012
14Drug Therapy (Chemotherapy)
01/2024 - 04/2012
2Radiotherapy
09/2023 - 07/2012
2Castration
01/2018 - 12/2015
1Duration of Therapy
01/2024
1Molecular Targeted Therapy
04/2023
1Nutritional Support (Artificial Feeding)
01/2022
1Combination Drug Therapy (Combination Chemotherapy)
08/2019